Log In
BCIQ
Print this Print this
 

Influenza virus-like particles (VLPs)

  Manage Alerts
Collapse Summary General Information
Company Takeda Pharmaceutical Co. Ltd.
DescriptionVaccine containing LigoCyte's chimeric virus-like particle technology
Molecular Target
Mechanism of Action 
Therapeutic ModalityPreventive vaccine: Viral vaccine
Latest Stage of DevelopmentPreclinical
Standard IndicationInfluenza virus
Indication DetailsPrevent influenza virus infection
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today